К. В. Алексеев

ORCID: 0000-0003-3506-9051
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Drug Solubulity and Delivery Systems
  • Analytical Chemistry and Chromatography
  • Analytical Methods in Pharmaceuticals
  • Protein purification and stability
  • Pharmacological Effects of Natural Compounds
  • Advanced Drug Delivery Systems
  • Polymer Synthesis and Characterization
  • Medicinal plant effects and applications
  • Neurological Disorders and Treatments
  • Crystallization and Solubility Studies
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Adsorption, diffusion, and thermodynamic properties of materials
  • Biochemical effects in animals
  • Chromatography in Natural Products
  • 3D Printing in Biomedical Research
  • Computational Drug Discovery Methods
  • Medical and Biological Sciences
  • Gas Dynamics and Kinetic Theory
  • Biopolymer Synthesis and Applications
  • Additive Manufacturing and 3D Printing Technologies
  • Chemical Thermodynamics and Molecular Structure
  • Chemical synthesis and pharmacological studies
  • Nanoparticle-Based Drug Delivery
  • Fluid Dynamics and Heat Transfer
  • Advanced Scientific Research Methods

Russian Academy of Sciences
2009-2025

Institute of Pharmacology Russian Academy of Medical Sciences
2010-2024

Military Space Academy named after AF Mozhaisky
2012-2023

Institute of Pharmacology
2020-2022

Samara Medical Institute Reaviz
2017-2021

Pharmaceutical Biotechnology (Czechia)
2014

Academy of Medical Sciences
2009-2013

Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care"
2010

Peoples' Friendship University of Russia
2004

Amorphous solid dispersion (ASD) technology is often used as a promising strategy to improve the solubility of active pharmaceutical ingredients (APIs). ASDs allow APIs be dispersed at molecular level in polymer carrier, destroying crystalline structure and, thanks polymer, providing long-term supersaturation solution. However, stability issues are an obstacle development new medications with ASD. In addition mobility elevated temperatures leading crystallization APIs, moisture affects...

10.3390/ma18010203 article EN Materials 2025-01-06

Epiphytic lichens are integral to boreal forest ecosystems, yet their allelopathic interactions with host trees, particularly in cryolithozone regions, remain poorly understood. This study elucidates the physiological and biochemical impacts of epiphytic lichen Physcia alnophila on Larix gmelinii (Gmelin larch), a keystone species Siberian permafrost forests. By combining dendrochronology, GC–MS metabolomic analysis, HPLC–ESI–MS/MS we demonstrate that lichen’s primary metabolite, atranorin...

10.3390/f16050711 article EN Forests 2025-04-22

To this day, the proper production of medicines according to Good Manufacturing Practice (GMP) largely depends on professional training pharmaceutical staff. This article describes approaches selection and employees enterprises methods for evaluating staff knowledge.

10.33920/med-13-2502-01 article EN 2025-04-10

This work aimed to develop and characterize a water-soluble, high-release active pharmaceutical ingredient (API) composite based on the practically water-insoluble API N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3-carboxamide (GML-3), substance with antidepressant anxiolytic action. allows ensure bioavailability of medicinal product combined Composites obtained by method creating amorphous solid dispersions, where polyvinylpyrrolidone (PVP) or Soluplus® was used as polymer, were studied...

10.3390/ijms241512215 article EN International Journal of Molecular Sciences 2023-07-30

Lyophilization of protein and peptide anticancer drugs is a promising method to create stable effective parenteral dosage forms. This article reviews the main problems encountered during lyophilization drugs, describes best practices for solving these problems. The ways optimization improvement freeze-drying are given. Temperatures improve properties prevent destruction cake lyophilizatiе suggested.

10.17650/1726-9784-2017-16-1-6-11 article EN cc-by Russian Journal of Biotherapy 2017-03-30

N-butyl-N-methyl-1-phenylpyrrole[1,2-a] pyrazine-3-carboxamide (GML-3) is a potential candidate for combination drug therapy due to its anxiolytic and antidepressant activity. The activity of GML-3 comparable diazepam. amitriptyline. an 18 kDa mitochondrial translocator protein (TSPO) ligand devoid most the side effects diazepam, which makes research on creation drugs based it promising. However, low water solubility tendency agglomerate prevented release. This aimed study effect dry...

10.3390/polym15204136 article EN Polymers 2023-10-18

10.26787/nydha-2226-7425-2017-19-12-297-301 article EN The Journal of scientific articles Health and Education millennium 2017-12-30

Nearly 40% of novel chemical entities show evidence low solubility in water and bioavailability. Self-emulsifying formulations have showed the power to improve bioavailability hydrophobic drugs. belong lipid formulations, their size range from 100 nm case self-emulsifying drug delivery systems less than 50 self-microemulsifying systems. In general s represent isotropic mixtures oils, surfactants co-surfactants, which emulsify spontaneous aqueous media under conditions gentle stirring....

10.12737/3320 article EN Journal of New Medical Technologies 2014-06-04
Coming Soon ...